Shopping Cart
Remove All
Your shopping cart is currently empty
L-2'-Fd4C is an L-nucleoside analogue with both anti-human immunodeficiency virus (HIV) and anti-hepatitis B virus (HBV) activity [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,140 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,785 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $3,520 | 10-14 weeks | 10-14 weeks |
| Description | L-2'-Fd4C is an L-nucleoside analogue with both anti-human immunodeficiency virus (HIV) and anti-hepatitis B virus (HBV) activity [1]. |
| In vitro | L-2'-Fd4C (0-10 μM; 9 d; HepG2-2.2.15 cells) inhibits hepatitis B virus (HBV) replication with an EC50 of 0.002 μM [1]. |
| In vivo | L-2'-Fd4C, administered intraperitoneally at a dosage of 100 mg/kg daily for 7 days, demonstrates significant anti-hepadnaviral activity in HBV-transgenic mice, resulting in a reduction of hepatitis B virus (HBV) levels in the blood comparable to the effects of Lamivudine [1]. |
| Molecular Weight | 227.19 |
| Formula | C9H10FN3O3 |
| Cas No. | 221662-50-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.